Khiron Pharma ApS — Credit Rating and Financial Key Figures

CVR number: 37002984
Krogvej 1, Rejnstrup 4250 Fuglebjerg

Income statement (kDKK)

2016
2017
2018
2019
2020
Fiscal period length1212121212
Net sales
External services-13.61
Gross profit-13.61-10.25-7.50-7.25-6.50
EBIT-13.61-10.25-7.50-7.25-6.50
Other financial expenses-0.02-0.09-0.00
Net income from associates (fin.)-50.0032.4316.9364.39-68.67
Pre-tax profit-63.6322.099.4257.14-75.17
Income taxes0.816.88
Net earnings-63.6322.0910.2364.01-75.17

Assets (kDKK)

2017
2018
2019
2020
Intangible assets total
Tangible assets total
Holdings in group member companies32.4349.36113.7445.07
Investments total32.4349.36113.7445.07
Long term receivables total
Inventories total
Current deferred tax assets0.816.88
Short term receivables total0.816.88
Cash and bank deposits1.201.201.450.82
Cash and cash equivalents1.201.201.450.82
Balance sheet total (assets)33.6351.36122.0745.89

Equity and liabilities (kDKK)

2016
2017
2018
2019
2020
Share capital50.0050.0050.0050.0050.00
Other reserves63.74
Retained earnings-63.63-41.54-95.0532.71
Profit of the financial year-63.6322.0910.2364.01-75.17
Shareholders equity total-13.638.4618.6982.717.54
Non-current liabilities total
Current loans from credit institutions0.30
Current owed to group member8.3317.1724.6734.8633.98
Other non-interest bearing current liabilities5.008.008.004.504.38
Current liabilities total13.6325.1732.6739.3638.36
Balance sheet total (liabilities)33.6351.36122.0745.89
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.